Schmitz M - Search Results

1

Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8⁺ cytotoxic T cells.

Heidenreich F, Rücker-Braun E, Walz JS, Eugster A, Kühn D, Dietz S, Nelde A, Tunger A, Wehner R, Link CS, Middeke JM, Stölzel F, Tonn T, Stevanovic S, Rammensee HG, Bonifacio E, Bachmann M, Zeis M, Ehninger G, Bornhäuser M, Schetelig J, Schmitz M. Heidenreich F, et al. Among authors: schmitz m. Haematologica. 2017 Nov;102(11):e460-e464. doi: 10.3324/haematol.2017.167312. Epub 2017 Aug 24. Haematologica. 2017. PMID: 28838995 Free PMC article. No abstract available.

2

Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells.

Köhler T, Plettig R, Wetzstein W, Schmitz M, Ritter M, Mohr B, Schaekel U, Ehninger G, Bornhäuser M. Köhler T, et al. Among authors: schmitz m. Stem Cells. 2000;18(2):139-47. doi: 10.1634/stemcells.18-2-139. Stem Cells. 2000. PMID: 10742386

3

Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides.

Schmitz M, Diestelkoetter P, Weigle B, Schmachtenberg F, Stevanovic S, Ockert D, Rammensee HG, Rieber EP. Schmitz M, et al. Cancer Res. 2000 Sep 1;60(17):4845-9. Cancer Res. 2000. PMID: 10987296

4

Third international Dresden symposium on immunotherapy of cancer.

Schmitz M, Bornhauser M, Ockert D, Rieber EP. Schmitz M, et al. Cancer Res. 2001 Apr 15;61(8):3524-8. Cancer Res. 2001. PMID: 11309317 No abstract available.

5

Native human blood dendritic cells as potent effectors in antibody-dependent cellular cytotoxicity.

Schmitz M, Zhao S, Schäkel K, Bornhäuser M, Ockert D, Rieber EP. Schmitz M, et al. Blood. 2002 Aug 15;100(4):1502-4. Blood. 2002. PMID: 12149240 Free article.

6

Cancer immunotherapy: novel strategies and clinical experiences.

Schmitz M, Bornhäuser M, Ockert D, Rieber EP. Schmitz M, et al. Trends Immunol. 2002 Sep;23(9):428-9. doi: 10.1016/s1471-4906(02)02300-1. Trends Immunol. 2002. PMID: 12200057 No abstract available.

7

Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patients.

Kiessling A, Schmitz M, Stevanovic S, Weigle B, Hölig K, Füssel M, Füssel S, Meye A, Wirth MP, Rieber EP. Kiessling A, et al. Among authors: schmitz m. Int J Cancer. 2002 Dec 1;102(4):390-7. doi: 10.1002/ijc.10713. Int J Cancer. 2002. PMID: 12402309

8

Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8.

Kiessling A, Füssel S, Schmitz M, Stevanovic S, Meye A, Weigle B, Klenk U, Wirth MP, Rieber EP. Kiessling A, et al. Among authors: schmitz m. Prostate. 2003 Sep 1;56(4):270-9. doi: 10.1002/pros.10265. Prostate. 2003. PMID: 12858355

9

Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.

Babatz J, Röllig C, Oelschlägel U, Zhao S, Ehninger G, Schmitz M, Bornhäuser M. Babatz J, et al. Among authors: schmitz m. J Hematother Stem Cell Res. 2003 Oct;12(5):515-23. doi: 10.1089/152581603322448222. J Hematother Stem Cell Res. 2003. PMID: 14594508 Clinical Trial.

10

Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein.

Kiessling A, Stevanovic S, Füssel S, Weigle B, Rieger MA, Temme A, Rieber EP, Schmitz M. Kiessling A, et al. Among authors: schmitz m. Br J Cancer. 2004 Mar 8;90(5):1034-40. doi: 10.1038/sj.bjc.6601642. Br J Cancer. 2004. PMID: 14997204 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,456 results

Search Page

Filters